Carregant...
The Economic Burden of Systemic Lupus Erythematosus in Commercially- and Medicaid-insured Populations in the United States
OBJECTIVE: To estimate the economic burden of systematic lupus erythematous (SLE), stratified by disease severity, in commercially- and Medicaid-insured US populations METHODS: Adults (≥18 years) with SLE treated with antimalarials, selected biologics, immunosuppressants, and systemic glucocorticoid...
Guardat en:
| Publicat a: | Semin Arthritis Rheum |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857313/ https://ncbi.nlm.nih.gov/pubmed/32531505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semarthrit.2020.04.014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|